GHDX
T. Rowe Price Associates’s Genomic Health, Inc. GHDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-419,848
| Closed | -$28.5M | – | 2586 |
|
|
2019
Q3 | $28.5M | Sell |
419,848
-8,685
| -2% | -$589K | ﹤0.01% | 1043 |
|
|
2019
Q2 | $24.9M | Buy |
428,533
+5,279
| +1% | +$307K | ﹤0.01% | 1116 |
|
|
2019
Q1 | $29.6M | Buy |
423,254
+550
| +0.1% | +$38.5K | ﹤0.01% | 1049 |
|
|
2018
Q4 | $27.2M | Buy |
422,704
+35,726
| +9% | +$2.3M | ﹤0.01% | 1046 |
|
|
2018
Q3 | $27.2M | Buy |
386,978
+381,772
| +7,333% | +$26.8M | ﹤0.01% | 1118 |
|
|
2018
Q2 | $262K | Buy |
+5,206
| New | +$262K | ﹤0.01% | 2376 |
|
|
2017
Q4 | – | Sell |
-9,178
| Closed | -$295K | – | 2623 |
|
|
2017
Q3 | $295K | Buy |
9,178
+2,015
| +28% | +$64.8K | ﹤0.01% | 2274 |
|
|
2017
Q2 | $233K | Buy |
7,163
+3
| +0% | +$98 | ﹤0.01% | 2322 |
|
|
2017
Q1 | $225K | Hold |
7,160
| – | – | ﹤0.01% | 2359 |
|
|
2016
Q4 | $210K | Buy |
7,160
+230
| +3% | +$6.75K | ﹤0.01% | 2369 |
|
|
2016
Q3 | $200K | Sell |
6,930
-2,320
| -25% | -$67K | ﹤0.01% | 2354 |
|
|
2016
Q2 | $240K | Buy |
9,250
+100
| +1% | +$2.6K | ﹤0.01% | 2255 |
|
|
2016
Q1 | $227K | Buy |
9,150
+200
| +2% | +$4.96K | ﹤0.01% | 2261 |
|
|
2015
Q4 | $315K | Buy |
+8,950
| New | +$315K | ﹤0.01% | 2136 |
|